Stay updated on Nivolumab in Advanced SqNSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.

Latest updates to the Nivolumab in Advanced SqNSCLC Clinical Trial page
- Check5 days agoChange DetectedThe site revision number in the footer changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe deletions remove sponsor/organization details, study documents references, and the full list of participating locations from the study page, altering what a reader can see about who runs the trial, what materials are provided, and where the trial is conducted. This changes what a prospective participant would see when evaluating the study.SummaryDifference17%

- Check26 days agoChange DetectedThe page now shows Revision: v3.7.0 instead of v3.6.6. This indicates an update to the page's documentation or content version without changing the study details presented.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded the revision label 'Revision: v3.6.6' and removed 'Revision: v3.6.5', signaling an updated page version. This metadata change does not affect the actual study details or page layout.SummaryDifference0.0%

- Check47 days agoChange DetectedA new funding note '2014 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH support for the trial. This addition provides funding context for the study.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page footer revision label changed from v3.6.4 to v3.6.5, indicating a newer version of the page.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Advanced SqNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced SqNSCLC Clinical Trial page.